Simcere Innovation is funded for aiming at leveraging global innovation resources and seeking more effective treatments for patients. Together with strong R&D in Oncology, Autoimmune diseases and CNS diseases in Simcere Pharmaceutical, we will continue the efforts to bring in cell and gene therapy pipeline into these disease areas.